Pathophysiology of cognitive dysfunction in older people with type 2 diabetes: vascular changes or neurodegeneration?

Age and Ageing
Hiroyuki Umegaki

Abstract

Recent studies have revealed that type 2 diabetes mellitus (T2DM) is a risk factor for cognitive dysfunction or dementia, especially those related to Alzheimer's disease (AD). Basic research suggests that insulin accelerates Alzheimer-related pathology through its effects on the amyloid beta (Abeta). Several pathological studies with autopsy samples have demonstrated, however, that dementia subjects with diabetes have less AD-related neuropathology than subjects without diabetes. We and others have reported that small vessel diseases affect cognitive function in older diabetics. Asymptomatic ischemic lesions in T2DM subjects may lower the threshold for the development of dementia and this may explain the inconsistency between the basic research and clinicopathological studies. Longitudinal follow-up of T2DM subjects without overt dementia using both amyloid imaging and magnetic resonance imaging may elucidate these issues. Following up until the development of overt dementia would make it possible to compare both amyloid load and ischemic lesions before and after the development of dementia. Moreover, amyloid imaging in non-demented older people with or without insulin resistance would verify the role of insulin in the processi...Continue Reading

References

May 6, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·R Stewart, D Liolitsa
May 19, 2004·Archives of Neurology·Zoe ArvanitakisDavid A Bennett
Sep 3, 2004·Journal of the American Geriatrics Society·Robert G RiekseDebby Tsuang
May 28, 2005·Magnetic Resonance Imaging·Vera NovakP M Robitaille
Jun 4, 2005·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Michal Schnaider BeeriVahram Haroutunian
Mar 23, 2006·Journal of the American Geriatrics Society·Mari SuzukiAkihisa Iguchi
Oct 9, 2007·Brain Research Reviews·Lin Li, Christian Hölscher
Mar 8, 2008·Stroke; a Journal of Cerebral Circulation·Alida A GouwUNKNOWN LADIS Study Group
Mar 15, 2008·Brain : a Journal of Neurology·Milos D IkonomovicSteven T DeKosky
Jan 14, 2009·Archives of Neurology·Joshua A SonnenSuzanne Craft

❮ Previous
Next ❯

Citations

Jan 21, 2014·Acta Pharmacologica Sinica·Suo-bin Wang, Jian-ping Jia
Feb 15, 2012·Journal of Amino Acids·Wesley M WilliamsMark A Smith
Apr 17, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Rui LiHui Wang
Jul 24, 2013·Journal of Molecular Neuroscience : MN·Wenjing DengJunfang Teng
Jul 28, 2011·Wiener medizinische Wochenschrift·Bernhard Iglseder
Feb 18, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Elizabeth Guerrero-BerroaMichal Schnaider Beeri
Apr 14, 2012·Journal of Aging Research·Ana I DuarteCatarina R Oliveira
Feb 16, 2012·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Jasmin BartlEdna Grünblatt
Sep 21, 2018·The International Journal of Neuroscience·Bina Kumari MehtaSugato Banerjee
Jan 19, 2019·The Journal of Clinical Endocrinology and Metabolism·Anna ShalimovaKrzysztof Narkiewicz
Jul 20, 2011·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·A S AliF H Sarkar
Oct 13, 2011·American Journal of Physiology. Endocrinology and Metabolism·Hui WangJin-Ning Lou
Oct 3, 2019·Biomolecules·Bahare SalehiJavad Sharifi-Rad
Jul 1, 2020·Terapevticheskiĭ arkhiv·E V SurkovaA V Naminov
Apr 21, 2017·Frontiers in Neuroscience·Frank C G van BusselJacobus F A Jansen
Apr 1, 2012·Dementia & Neuropsychologia·Juliana Luchin Diniz SilvaYara Dadalti Fragoso
Jan 8, 2016·Metabolic Brain Disease·Piangkwan Sa-NguanmooSiriporn C Chattipakorn
May 15, 2020·Neurochemical Research·Adriana JiménezRosalinda Guevara-Guzmán

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.